Cited by 36Celiac Disease Research and ManagementEosinophilic EsophagitisGastrointestinal disorders and treatments

The DOI matches its Crossref record.

Coeliac disease in the ERA of the new ESPGHAN and BSPGHAN guidelines: a prospective cohort study

Open access

Abstract

Objective: To evaluate the consequences of the last European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and British Society of Paediatric Gastroenterology, Hepatology and Nutrition (BSPGHAN) guidelines for the diagnosis of coeliac disease (CD) by means of a prospective study. Design: Prospective cohort study. Setting: Institute for Maternal and Child Health IRCCS Burlo Garofolo (Trieste, Italy). Patients: Children diagnosed with CD without a duodenal biopsy (group 1), following the last ESPGHAN and BSPGHAN guidelines, and children diagnosed with a duodenal biopsy, matched for sex, age and year of diagnosis (group 2), were prospectively enrolled over a 3-year period. All patients were put on a gluten-free diet (GFD) and were followed up for clinical conditions and laboratory testing at 6 months every year since diagnosis (median follow up: 1.9 years). Outcome measures: Resolution of symptoms, body mass index, laboratory testing (haemoglobin, anti-transglutaminase IgA), adherence to a GFD, quality of life, and supplementary post-diagnosis medical consultations. Results: 51 out of 468 (11%) patients were diagnosed without a duodenal biopsy (group 1; median age 2.1 years) and matched to 92 patients diagnosed with a biopsy (group 2; median age 2.4 years). At the end of follow-up the two groups were statistically comparable in terms of clinical and nutritional status, anti-transglutaminase IgA antibody titres, quality of life, adherence to a GFD, and number of supplementary medical consultations. Conclusions: On the basis of this prospective study, diagnosis of CD can be reliably performed without a duodenal biopsy in approximately 11% of cases. At least during a medium-term follow-up, this approach has no negative consequences relating to clinical remission, adherence to diet, and quality of life of children with CD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/archdischild-2015-309259

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Five of six studies using celiac disease-specific health-related quality of life questionnaires found that the health-related quality of life of children and adolescents with celiac disease was poor or neutral.

    “However, five of the six studies using CD-specific HRQOL questionnaires (CDDUX, CDQL, CDQOL Scale-KINDL, CDPQOL) found that the HRQOL of children and adolescents with CD was poor or neutral (82, 96, 100, 105, 109).”

    From ESPGHAN Position Paper on Management and Follow-up of Children and Adolescents With Celiac Disease. (2022) · cites this paper as [82]

    The Follow-up and diet section says the study used a simplified Kindl test to assess quality of life. Contrary to the outcome attributed to it, the Discussion reports that all patients felt “good or very good” at the last follow-up visit. The paper does not report a five-of-six-studies tally. (LLM, conf=0.88)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured
  • Nine studies found similar health-related quality of life in children with celiac disease as in control children.

    “Nine of these studies found similar HRQOL in children with CD as in control children (4, 82, 95, 96, 99, 100, 102, 103, 106).”

    From ESPGHAN Position Paper on Management and Follow-up of Children and Adolescents With Celiac Disease. (2022) · cites this paper as [82]

    The Results (page unavailable) report similar quality-of-life scores in two groups of children with coeliac disease: those diagnosed with and without a biopsy. The paper does not compare children with coeliac disease against control children, so it does not support the stated comparator. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 14

  1. Husby, 2012, European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease, J Pediatr Gastroenterol Nutr, 54, 136, 10.1097/MPG.0b013e31821a23d0 · DOI · Paper page
  2. [No authors listed]. Revised criteria for diagnosis of coeliac disease. Report of Working Group of European Society of Paediatric Gastroenterology and Nutrition. Arch Dis Child 1990;65:909–11. · DOI
  3. Murch, 2013, Joint BSPGHAN and Coeliac UK guidelines for the diagnosis and management of coeliac disease in children, Arch Dis Child, 98, 806, 10.1136/archdischild-2013-303996 · DOI
  4. Nevoral, 2014, Symptom positivity is essential for omitting biopsy in children with suspected celiac disease according to the new ESPGHAN guidelines, Eur J Pediatr, 173, 497, 10.1007/s00431-013-2215-0 · DOI
  5. Klapp, 2013, Celiac disease: the new proposed ESPGHAN diagnostic criteria do work well in a selected population, J Pediatr Gastroenterol Nutr, 56, 251, 10.1097/MPG.0b013e318279887b · DOI
  6. Gidrewicz, 2015, Evaluation of the ESPGHAN Celiac Guidelines in a North American Pediatric Population, Am J Gastroenterol, 110, 760, 10.1038/ajg.2015.87 · DOI
  7. Oberhuber, 1999, The histopathology of coeliac disease: time for a standardized report scheme for pathologists, Eur J Gastroenterol Hepatol, 11, 1185, 10.1097/00042737-199910000-00019 · DOI
  8. Biagi, 2009, A gluten-free diet score to evaluate dietary compliance in patients with coeliac disease, Br J Nutr, 102, 882, 10.1017/S0007114509301579 · DOI
  9. Bellini, 2011, Compliance with the gluten-free diet: the role of locus of control in celiac disease, J Pediatr, 158, 463, 10.1016/j.jpeds.2010.08.034 · DOI · Paper page
  10. Benelli, 2011, Coeliac disease: no more biopsies?, Medico e Bambino, 30, 493
  11. Cilleruelo, 2014, A Spanish national registry of celiac disease: incidence and clinical presentation, J Pediatr Gastroenterol Nutr, 59, 522, 10.1097/MPG.0000000000000446 · DOI
  12. Hogen Esch, 2011, Specific celiac disease antibodies in children on a gluten-free diet, Pediatrics, 128, 547, 10.1542/peds.2010-3762 · DOI · Paper page
  13. Vahedi, 2003, Reliability of antitransglutaminase antibodies as predictors of gluten-free diet compliance in adult celiac disease, Am J Gastroenterol, 98, 1079, 10.1111/j.1572-0241.2003.07284.x · DOI
  14. Lee, 2003, Celiac diet: its impact on quality of life, J Am Diet Assoc, 103, 1533, 10.1016/j.jada.2003.08.027 · DOI

Cited by

Sorted by citations

Metadata

Authors
Benelli, E., Carrato, V., Martelossi, S., Ronfani, L., Not, T., & Ventura, A.
Affiliations
  • University of Trieste (IT)
  • IRCCS Materno Infantile Burlo Garofolo (IT)
Corresponding author
Benelli, Elisa
Venue
Archives of Disease in Childhood
Publisher
BMJ
Published
2015-11-17
Volume
101
Issue
2
Pages
172-176
ISSN
  • 0003-9888 (ISSN-L)
  • 1468-2044
OpenAlex
W2175881665
Cited by
36
References
0
Citations by year
2026: 2 · 2024: 5 · 2022: 2 · 2021: 3 · 2020: 5 · 2019: 2 · 2018: 5 · 2017: 9 · 2016: 2
FWCI
5.59
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Archives of Disease in Childhood (publishedVersion)
  • PubMed (publishedVersion)
  • ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion, cc-by-nc)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Celiac Disease Research and Management
  • Health Sciences › Medicine › Gastroenterology › Eosinophilic Esophagitis
  • Health Sciences › Medicine › Surgery › Gastrointestinal disorders and treatments
Keywords
celiac disease, non-biopsy diagnosis, duodenal biopsy, ESPGHAN guidelines, children, gluten-free diet adherence, quality of life, clinical remission, nutritional status
MeSH terms
Adolescent, Biopsy, Celiac Disease, Child, Child, Preschool, Duodenum, Female, Humans, Immunoglobulin A, Infant, Infant, Newborn, Italy, Male, Patient Compliance, Prospective Studies, Transglutaminases, Quality of Life, Cohort Studies, Practice Guidelines as Topic, Age Distribution, Unnecessary Procedures, Diet, Gluten-Free

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review